PMH40 - COST-MINIMISATION ANALYSIS OF SECOND GENERATION...

Value in Health 2018 / 10 Vol. 21

PMH40 - COST-MINIMISATION ANALYSIS OF SECOND GENERATION LONG ACTING INJECTABLES (RISPERIDONE , PALIPERIDONE, AND ARIPIPRAZOLE) FOR SCHIZOPHRENIA IN SPANISH MEDIUM-LONG TERM CARE PSYCHIATRIC UNITS

Echarri, E., Martinez, A.I., Gutierrez, F., De Sancho, I., Lopez-lunar, E., Iriarte, M.A., Rodriguez-Garcia, E., Martinez-deGuzman, M., Provencio, R.M., Sanz-Pamplona, S., Gonzalez-Martin, C., Longoni
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.1675
Date:
October, 2018
File:
PDF, 385 KB
2018
Conversion to is in progress
Conversion to is failed